On August 30, 2022 Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, reported the Company will participate in person at three upcoming investor conferences in September 2022 (Press release, Alpha Tau Medical, AUG 30, 2022, View Source [SID1234618764]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Citi’s 17th Annual BioPharma Conference
Date: Wednesday, September 7,2022
Location: Boston, MA
Format: 1:1 Meetings

Event: Cantor Oncology, Hematology & HemeOnc Conference
Date: Wednesday, September 28th, 2022
Location: New York, NY
Format: Group Panel and 1:1 Meetings

Event: Ladenburg Thalmann Annual Healthcare Conference
Date: Thursday, September 29th, 2022
Location: New York, NY
Format: Company Presentation and 1:1 Meetings

Additional information can be found on the Events and Presentations section of Alpha Tau’s investor website, www.alphatau.com/events. If you would like to schedule a 1:1 meeting, please contact the appropriate institutional representative.